Leaderboards/lipoproteins and cardiovascular health

lipoproteins and cardiovascular health

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Mingxuan Duan
First Affiliated Hospital of Zhengzhou University
80
2
Xiaoyan Zhao
First Affiliated Hospital of Zhengzhou University
70
3
Binyang Yu
Chinese Academy of Medical Sciences & Peking Union Medical College
60
4
Rui Gao
Chinese Academy of Medical Sciences & Peking Union Medical College
50
5
De-Gang Mo
Qingdao University
40
6
Yanqiu Huang
Shanghai Jiao Tong University
30
7
Jun Guan
Qingdao Municipal Hospital
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Tian Wang
The University of Sydney
99
2
Qianqian Min
Jinggangshan University
90
3
Xiaoyi Qi
Shantou University Medical College
80
4
Harpreet Bhatia
University of California San Diego
70
5
Adriana Roca‐Fernández
Unknown
60
6
Matthew J. Landry
University of California, Irvine
40
7
Seth S. Martin
Johns Hopkins University
30
8
Seema Mehdi
Columbia University
20
9
Weifang Liu
Wuhan University
10

Emerging Leaders Papers

1
Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi‐Ethnic Study of Atherosclerosis
Journal of the American Heart Association|2024
69 cit.
2
Inhibition of VEGFR-3 by SAR131675 decreases renal inflammation and lymphangiogenesis in the murine lupus nephritis model
Cell Death Discovery|2025
2 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
William H. Dietz
Unknown
99
2
Antonio M. Gotto
Cornell University
90
3
Paul M. Ridker
Brigham and Women's Hospital
80
4
Carlos Fernández‐Hernando
New York University
70
5
William B. Kannel
American Heart Association
60
6
E. Chester Ridgway
University of Colorado Denver
50
7
Jean Allen
R&D Systems (United States)
40
8
Majid Ezzati
Harvard University
30
9
Jane Morley Kotchen
Medical College of Wisconsin
20
10
Catherine M Otto
National Institutes of Health
10

All-Time Leaders Papers

1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
New England Journal of Medicine|2017
9k cit.
2
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
The Lancet|2011
4.1k cit.
3
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
New England Journal of Medicine|2002
3.6k cit.
4
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
PLoS Medicine|2009
2.9k cit.
5
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events
New England Journal of Medicine|2001
1.6k cit.
6
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Nature Reviews Cardiology|2021
1.5k cit.
7
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
The Lancet|2017
1.3k cit.
8
A molecular theory of lipid—protein interactions in the plasma lipoproteins
FEBS Letters|1974
723 cit.
9
Dietary Calcium, Vitamin D, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women
Diabetes Care|2005
444 cit.
10
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Journal of Thrombosis and Haemostasis|2009
270 cit.

Reagents for lipoproteins and cardiovascular health

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

Phospho-HS1 (Tyr378/397) (D12C1) Rabbit Monoclonal Antibody

Cited in 6 papers
#8714$179
View Evidence →Cell Signaling Technology

WSTF Antibody

Cited in 6 papers
#2152$317
View Evidence →Cell Signaling Technology

Stat3 (D1B2J) Rabbit Monoclonal Antibody

Cited in 6 papers
#30835$167
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

Cited in 14 papers
#95159$465
View Evidence →Cell Signaling Technology

MAP2 (D5G1) Rabbit Monoclonal Antibody

Cited in 7 papers
#8707$161
View Evidence →Cell Signaling Technology

SignalSilence® Akt siRNA I

Cited in 6 papers
#6211$381
View Evidence →